SJG-136

SJG-136 Uses, Dosage, Side Effects, Food Interaction and all others data.

SJG-136 has been used in trials studying the treatment of Recurrent Fallopian Tube Cancer, Secondary Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes, Recurrent Ovarian Epithelial Cancer, and Secondary Myelodysplastic Syndromes, among others.

Trade Name SJG-136
Generic SJG-136
Type
Formula C31H32N4O6
Weight Average: 556.619
Monoisotopic: 556.232184766
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
SJG-136
SJG-136

Innovators Monograph

You find simplified version here SJG-136

*** Taking medicines without doctor's advice can cause long-term problems.
Share